ARALEZ PHARMACEUTICALS INC. Stock-Based Compensation
ARALEZ PHARMACEUTICALS INC. reported Stock-Based Compensation of $1.76 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2018-05-08
- ARALEZ PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2018-03-31 was $1.76M, a 37.68% decline year-over-year.
- ARALEZ PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2017-12-31 was $2.61M, a 1.99% decline year-over-year.
- ARALEZ PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2017-09-30 was $2.96M, a 11.36% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2017-06-30 was $2.95M, a 12.15% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2017 was $11.35M, a 4.36% decline from fiscal 2016.
- ARALEZ PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2016 was $11.87M, a 68.47% increase from fiscal 2015.
- ARALEZ PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2015 was $7.04M, a 274.43% increase from fiscal 2014.
- ARALEZ PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2014 was $1.88M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2018-03-31 | $1.76M 10-Q · filed 2018-05-08 | $4.37M derived: sum of 2 quarters · filed 2018-05-08 | $7.33M derived: sum of 3 quarters · filed 2018-05-08 | $10.28M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $5.57M derived: sum of 2 quarters · filed 2018-03-14 | $8.52M derived: sum of 3 quarters · filed 2018-03-14 | $11.35M 10-K · filed 2018-03-14 |
| 2017-09-30 | $2.96M 10-Q · filed 2017-11-09 | $5.91M derived: sum of 2 quarters · filed 2017-11-09 | $8.74M 10-Q · filed 2017-11-09 | $11.40M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-06-30 | $2.95M 10-Q · filed 2017-08-09 | $5.78M 10-Q · filed 2017-08-09 | $8.44M derived: sum of 3 quarters · filed 2018-05-08 | $11.10M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-03-31 | $2.82M 10-Q · filed 2018-05-08 | $5.49M derived: sum of 2 quarters · filed 2018-05-08 | $8.15M derived: sum of 3 quarters · filed 2018-05-08 | $10.78M derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $2.66M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $5.32M derived: sum of 2 quarters · filed 2018-03-14 | $7.96M derived: sum of 3 quarters · filed 2018-03-14 | $11.87M 10-K · filed 2018-03-14 |
| 2016-09-30 | $2.66M 10-Q · filed 2017-11-09 | $5.29M derived: sum of 2 quarters · filed 2017-11-09 | $9.20M 10-Q · filed 2017-11-09 | $10.57M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $2.63M 10-Q · filed 2017-08-09 | $6.54M 10-Q · filed 2017-08-09 | $7.91M derived: sum of 3 quarters · filed 2018-03-14 | $9.88M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $3.91M 10-Q · filed 2017-05-09 | $5.28M derived: sum of 2 quarters · filed 2018-03-14 | $7.25M derived: sum of 3 quarters · filed 2018-03-14 | $10.48M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $3.34M derived: sum of 2 quarters · filed 2018-03-14 | $6.57M derived: sum of 3 quarters · filed 2018-03-14 | $7.04M 10-K · filed 2018-03-14 |
| 2015-09-30 | $1.97M 10-Q · filed 2016-11-08 | $5.20M derived: sum of 2 quarters · filed 2016-11-08 | $5.67M 10-Q · filed 2016-11-08 | |
| 2015-06-30 | $3.23M 10-Q · filed 2016-08-09 | $3.71M 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $477.00K 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $1.88M 10-K · filed 2017-03-13 |